Cargando…

Symptoms and signs of urogenital cancer in primary care

BACKGROUND: Urogenital cancers are common, accounting for approximately 20% of cancer incidence globally. Cancers belonging to the same organ system often present with similar symptoms, making initial management challenging. In this study, 511 cases of cancer were recorded after the date of consulta...

Descripción completa

Detalles Bibliográficos
Autores principales: Holtedahl, Knut, Borgquist, Lars, Donker, Gé A., Buntinx, Frank, Weller, David, Campbell, Christine, Månsson, Jörgen, Hammersley, Victoria, Braaten, Tonje, Parajuli, Ranjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131418/
https://www.ncbi.nlm.nih.gov/pubmed/37101110
http://dx.doi.org/10.1186/s12875-023-02063-z
_version_ 1785031173674631168
author Holtedahl, Knut
Borgquist, Lars
Donker, Gé A.
Buntinx, Frank
Weller, David
Campbell, Christine
Månsson, Jörgen
Hammersley, Victoria
Braaten, Tonje
Parajuli, Ranjan
author_facet Holtedahl, Knut
Borgquist, Lars
Donker, Gé A.
Buntinx, Frank
Weller, David
Campbell, Christine
Månsson, Jörgen
Hammersley, Victoria
Braaten, Tonje
Parajuli, Ranjan
author_sort Holtedahl, Knut
collection PubMed
description BACKGROUND: Urogenital cancers are common, accounting for approximately 20% of cancer incidence globally. Cancers belonging to the same organ system often present with similar symptoms, making initial management challenging. In this study, 511 cases of cancer were recorded after the date of consultation among 61,802 randomly selected patients presenting in primary care in six European countries: a subgroup analysis of urogenital cancers was carried out in order to study variation in symptom presentation. METHODS: Initial data capture was by completion of standardised forms containing closed questions about symptoms recorded during the consultation. The general practitioner (GP) provided follow-up data after diagnosis, based on medical record data made after the consultation. GPs also provided free text comments about the diagnostic procedure for individual patients. RESULTS: The most common symptoms were mainly associated with one or two specific types of cancer: ‘Macroscopic haematuria’ with bladder or renal cancer (combined sensitivity 28.3%), ‘Increased urinary frequency’ with bladder (sensitivity 13.3%) or prostatic (sensitivity 32.1%) cancer, or to uterine body (sensitivity 14.3%) cancer, ‘Unexpected genital bleeding’ with uterine cancer (cervix, sensitivity 20.0%, uterine body, sensitivity 71.4%). ‘Distended abdomen, bloating’ had sensitivity 62.5% (based on eight cases of ovarian cancer). In ovarian cancer, increased abdominal circumference and a palpable tumour also were important diagnostic elements. Specificity for ‘Macroscopic haematuria’ was 99.8% (99.7–99.8). PPV > 3% was noted for ‘Macroscopic haematuria’ and bladder or renal cancer combined, for bladder cancer in male patients. In males aged 55–74, PPV = 7.1% for ‘Macroscopic haematuria’ and bladder cancer. Abdominal pain was an infrequent symptom in urogenital cancers. CONCLUSIONS: Most types of urogenital cancer present with rather specific symptoms. If the GP considers ovarian cancer, increased abdominal circumference should be actively determined. Several cases were clarified through the GP’s clinical examination, or laboratory investigations.
format Online
Article
Text
id pubmed-10131418
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101314182023-04-27 Symptoms and signs of urogenital cancer in primary care Holtedahl, Knut Borgquist, Lars Donker, Gé A. Buntinx, Frank Weller, David Campbell, Christine Månsson, Jörgen Hammersley, Victoria Braaten, Tonje Parajuli, Ranjan BMC Prim Care Research BACKGROUND: Urogenital cancers are common, accounting for approximately 20% of cancer incidence globally. Cancers belonging to the same organ system often present with similar symptoms, making initial management challenging. In this study, 511 cases of cancer were recorded after the date of consultation among 61,802 randomly selected patients presenting in primary care in six European countries: a subgroup analysis of urogenital cancers was carried out in order to study variation in symptom presentation. METHODS: Initial data capture was by completion of standardised forms containing closed questions about symptoms recorded during the consultation. The general practitioner (GP) provided follow-up data after diagnosis, based on medical record data made after the consultation. GPs also provided free text comments about the diagnostic procedure for individual patients. RESULTS: The most common symptoms were mainly associated with one or two specific types of cancer: ‘Macroscopic haematuria’ with bladder or renal cancer (combined sensitivity 28.3%), ‘Increased urinary frequency’ with bladder (sensitivity 13.3%) or prostatic (sensitivity 32.1%) cancer, or to uterine body (sensitivity 14.3%) cancer, ‘Unexpected genital bleeding’ with uterine cancer (cervix, sensitivity 20.0%, uterine body, sensitivity 71.4%). ‘Distended abdomen, bloating’ had sensitivity 62.5% (based on eight cases of ovarian cancer). In ovarian cancer, increased abdominal circumference and a palpable tumour also were important diagnostic elements. Specificity for ‘Macroscopic haematuria’ was 99.8% (99.7–99.8). PPV > 3% was noted for ‘Macroscopic haematuria’ and bladder or renal cancer combined, for bladder cancer in male patients. In males aged 55–74, PPV = 7.1% for ‘Macroscopic haematuria’ and bladder cancer. Abdominal pain was an infrequent symptom in urogenital cancers. CONCLUSIONS: Most types of urogenital cancer present with rather specific symptoms. If the GP considers ovarian cancer, increased abdominal circumference should be actively determined. Several cases were clarified through the GP’s clinical examination, or laboratory investigations. BioMed Central 2023-04-26 /pmc/articles/PMC10131418/ /pubmed/37101110 http://dx.doi.org/10.1186/s12875-023-02063-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Holtedahl, Knut
Borgquist, Lars
Donker, Gé A.
Buntinx, Frank
Weller, David
Campbell, Christine
Månsson, Jörgen
Hammersley, Victoria
Braaten, Tonje
Parajuli, Ranjan
Symptoms and signs of urogenital cancer in primary care
title Symptoms and signs of urogenital cancer in primary care
title_full Symptoms and signs of urogenital cancer in primary care
title_fullStr Symptoms and signs of urogenital cancer in primary care
title_full_unstemmed Symptoms and signs of urogenital cancer in primary care
title_short Symptoms and signs of urogenital cancer in primary care
title_sort symptoms and signs of urogenital cancer in primary care
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131418/
https://www.ncbi.nlm.nih.gov/pubmed/37101110
http://dx.doi.org/10.1186/s12875-023-02063-z
work_keys_str_mv AT holtedahlknut symptomsandsignsofurogenitalcancerinprimarycare
AT borgquistlars symptomsandsignsofurogenitalcancerinprimarycare
AT donkergea symptomsandsignsofurogenitalcancerinprimarycare
AT buntinxfrank symptomsandsignsofurogenitalcancerinprimarycare
AT wellerdavid symptomsandsignsofurogenitalcancerinprimarycare
AT campbellchristine symptomsandsignsofurogenitalcancerinprimarycare
AT manssonjorgen symptomsandsignsofurogenitalcancerinprimarycare
AT hammersleyvictoria symptomsandsignsofurogenitalcancerinprimarycare
AT braatentonje symptomsandsignsofurogenitalcancerinprimarycare
AT parajuliranjan symptomsandsignsofurogenitalcancerinprimarycare